MMM17-Cameroon, analysis and opportunities—Sub-Saharan Africa. (24th April 2019)

• Record Type: Journal Article
• Authors: Dzudie, Anastase; Djomou, Armel; Ba, Hamadou; Njume, Epie; Ndom, Marie Solange; Mfekeu, Liliane Kuate; Ndongo, Sylvie; Kouam, Charles Kouam; Awungia, Alexis; Ze, Stephane; Menanga, Alain; Kengne, Andre Pascal; Xia, Xin; Beaney, Thomas; Poulter, Neil R; Kingue, Samuel
• Is Part Of: European heart journal supplements. Volume 21(2019)Supplement D
• Page Start: D31
• Page End: D33
• Publication Date: 2019-04-24
• Subjects: Cardiology -- Periodicals; Cardiology -- Europe -- Periodicals; 616.12005
• DOI: 10.1093/eurheartj/suz081
• Languages: English
• ISSNs: 1520-765X

Abstract

Abstract: Elevated blood pressure (BP) is a growing burden worldwide, leading to over 10 million deaths each year. May Measurement Month (MMM) is a global initiative aimed at raising awareness on high BP and temporary increasing screening for hypertension worldwide. We here provide the results of the 2017 MMM (MMM17) edition in Cameroon. An opportunistic cross-sectional survey of volunteers aged ≥18 was carried out in May 2017 nationwide. BP measurement, the definition of hypertension and statistical analysis followed the standard MMM protocol. The campaign was advertised through various media and screening stations were set-up in local markets, churches, and outpatient departments of health facilities. In all, 16 093 individuals were screened during MMM17, of whom 4595 (29.2%) had hypertension. A total of 2742 (19.8%) of individuals not receiving anti-hypertensive medication were found to be hypertensive. Of those on medication, 1048 (57.2%) had uncontrolled BP. After adjusting for age, sex, and use of BP lowing medications, systolic and diastolic BPs were significantly higher in people on anti-hypertensive treatment, with higher waist circumference. MMM17 was the largest BP screening campaign undertaken in Cameroon, and although treatment and control rates are higher than previously reported, they are still well below optimum levels. MMM has highlighted the need for routine population-based surveys and suggests that opportunistic screening can identify significant numbers with raised BP.